$CERS..looks like transfusions could be the way to go. The most efficient & cost-effective measure moving forward. The FDA has already granted them an IDE so they are definitely on their list for assisting with rare & terminal diseases.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.